GlassScriptPhysician profile
Dat X Vu
NPI 1982151353
$1,210.22
in general payments reported to CMS, 2019-2025
6 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 99% of Anesthesiologist Assistant providers received nationally (typical 2025 total: $34.52).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.93 · 2022: $16.47 · 2023: $98.77 · 2024: $36.16 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $840 · Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $840.00 |
| Food and Beverage | $318.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $840.00 | 2025 | Bd Intelliport |
| Merck Sharp & Dohme LLC | $167.41 | 2021-2025 | Bridion |
| Fisher & Paykel Healthcare INC | $110.39 | 2025 | Fisher & Paykel Healthcare |
| Pacira Pharmaceuticals Incorporated | $38.43 | 2024-2025 | Exparel |
| Masimo Corporation | $35.66 | 2023 | Sedline |
| Acacia Pharma INC | $18.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dat Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.